Slide background

Slide background
Slide background
Slide background

Loading Events
Breast Cancer & Genomics: BRCA & Beyond
New York Genome Center
6:30 PM — 8:30 PM

Yaniv Erlich, PhD, Dan A. Landau, MD, PhD and Frances M. Visco

See New York Genome Center’s lecture series, events and archives VIEW FULL CALENDAR


Breast Cancer & Genomics: BRCA & Beyond
This free consumer lecture and audience Q & A is part of the New York Genome Center’s “Evening Talks” lecture series. Panelists will discuss the National Breast Cancer Coalition’s goal of eradicating breast cancer by 2020; the challenges of immunotherapy as a breast cancer treatment; how liquid biopsies might create new frontiers in breast cancer detection and how crowdsourcing genomic information can advance breast cancer treatment. A cocktail reception will follow.


Wednesday, May 31, 2017
6:30 to 8:30 PM


New York Genome Center Auditorium
101 Avenue of the Americas




Yaniv Erlich, PhD – Moderator
Core Member of the New York Genome Center
Assistant Professor, Department of Computer Science, Columbia University


Yaniv Erlich, PhD, is a Core Member and Assistant Investigator at the New York Genome Center (NYGC). He holds a joint appointment as Assistant Professor in the Computer Science Department at Columbia University. Dr. Erlich co-developed DNA.Land, a nonprofit website with 45,000 participants, which is designed to crowdsource genomic research. is partnering with the National Breast Cancer Coalition to create the largest breast cancer genomic database to advance treatment for breast cancer patients. Dr. Erlich’s research focuses on building new tools and algorithms for studying human genomics. He is developing new strategies at NYGC to harness datasets from millions of people from social media and scientific resources, and, in turn, dissect the genetic architecture of complex traits to work toward bridging the missing heritability gap.


Dan Landau, MD, PhD
Core Member of the New York Genome Center
Assistant Professor of Medicine, Physiology and Biophysics
at Weill Cornell Medicine


Dr. Dan Landau received his MD from Tel Aviv University and his PhD from Paris Diderot University. Dr. Landau was trained as a hematologist and oncologist at Yale University and completed a postdoctoral fellowship at the Broad Institute of Harvard and MIT. He has received numerous awards including from the Burroughs Wellcome Fund, Stand Up to Cancer and the National Institutes of Health Big Data to Knowledge initiative. His research focus is on developing new computational and experimental tools to study cancer evolution, and designing the next generation of precision medicine tools to help find a cure for cancer.


Frances M. Visco
National Breast Cancer Coalition


Ms. Frances Visco, a more than 25-year breast cancer survivor, is the president of the National Breast Cancer Coalition, and a member of its board of directors and executive committee. In 1993, President Clinton appointed Ms. Visco as one of three members of the President’s Cancer Panel, and she was the first consumer to chair the Integration Panel of the Department of Defense Peer-Review Breast Cancer Research Program.


To read more about Dr. Erlich’s research, please visit – Google Scholar – Yaniv Erlich, PhD


To read more about Dr. Landau’s research, please visit – Google Scholar – Dan Landau, MD, PhD


To read more about Ms. Visco’s research, please visit – Google Scholar – Frances Visco


  • +

    • Let us go on again, and plunge into the Five Points. — Charles Dickens, 1842

      Named for an early Manhattan crossroads – remembered as a rowdy but cosmopolitan gathering place, and as a nexus for progress in public health – the Five Points Lectures bring outstanding scientists from near and far, to discuss their work in technical detail* with researchers and clinicians from institutions served by NYGC, in order to strengthen our grasp of key biological questions and methods. Speakers present fresh and intriguing findings, along with thoughtful views on their respective fields, in full scientific depth. Talks last roughly 45 minutes — often framing five or so key points, in a nod to the series’ name — followed by 15 minutes of open Q&A, and 30 minutes of networking.

  • +